Acadia Healthcare (ACHC) Lowered to “Sell” at BidaskClub

BidaskClub lowered shares of Acadia Healthcare (NASDAQ:ACHC) from a hold rating to a sell rating in a research report sent to investors on Saturday morning.

Other equities research analysts have also recently issued research reports about the stock. Jefferies Financial Group reiterated a buy rating and set a $42.00 price target on shares of Acadia Healthcare in a report on Monday, November 26th. Citigroup cut their price target on shares of Acadia Healthcare from $46.00 to $43.00 and set a buy rating on the stock in a report on Wednesday, November 14th. Mizuho set a $37.00 price target on shares of Acadia Healthcare and gave the company a hold rating in a report on Thursday, October 18th. Cantor Fitzgerald reiterated a hold rating and set a $39.00 price target on shares of Acadia Healthcare in a report on Thursday, October 18th. Finally, Craig Hallum cut shares of Acadia Healthcare from a buy rating to a hold rating in a report on Wednesday, October 17th. They noted that the move was a valuation call. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have issued a buy rating to the stock. Acadia Healthcare presently has a consensus rating of Hold and an average price target of $42.27.

Shares of NASDAQ ACHC opened at $28.93 on Friday. Acadia Healthcare has a fifty-two week low of $28.02 and a fifty-two week high of $45.35. The company has a market cap of $2.55 billion, a price-to-earnings ratio of 12.58, a price-to-earnings-growth ratio of 1.27 and a beta of 0.16. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 1.19.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Monday, November 5th. The company reported $0.55 EPS for the quarter, missing the Zacks’ consensus estimate of $0.64 by ($0.09). Acadia Healthcare had a net margin of 7.43% and a return on equity of 7.71%. The firm had revenue of $760.90 million for the quarter, compared to analysts’ expectations of $760.46 million. During the same quarter in the previous year, the company earned $0.58 EPS. The company’s quarterly revenue was up 6.2% compared to the same quarter last year. On average, sell-side analysts anticipate that Acadia Healthcare will post 2.26 EPS for the current year.

In related news, Director Reeve B. Waud sold 41,865 shares of the firm’s stock in a transaction that occurred on Thursday, November 1st. The shares were sold at an average price of $45.00, for a total value of $1,883,925.00. Following the sale, the director now owns 14,213 shares in the company, valued at $639,585. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 2.50% of the company’s stock.

A number of hedge funds have recently modified their holdings of ACHC. Alpine Woods Capital Investors LLC purchased a new stake in Acadia Healthcare in the second quarter worth approximately $153,000. Jefferies Group LLC purchased a new stake in Acadia Healthcare in the third quarter worth approximately $225,000. Bbva Compass Bancshares Inc. boosted its holdings in Acadia Healthcare by 29.7% in the third quarter. Bbva Compass Bancshares Inc. now owns 8,222 shares of the company’s stock worth $289,000 after purchasing an additional 1,884 shares during the last quarter. Riverhead Capital Management LLC boosted its holdings in Acadia Healthcare by 30.7% in the third quarter. Riverhead Capital Management LLC now owns 8,524 shares of the company’s stock worth $300,000 after purchasing an additional 2,000 shares during the last quarter. Finally, Strs Ohio purchased a new stake in Acadia Healthcare in the third quarter worth approximately $308,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

Read More: Do You Need a Fiduciary?

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit